Insider Trading & Ownership - Watanabe Todd Franklin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Watanabe Todd Franklin
Goto Prev, 0, 1
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-05
Sale
2021-08-09
6:51 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,000 $20.81 $20,810 941,428
(Indirect
Direct)
View
2021-07-06
Sale
2021-07-08
7:40 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,750 $26.58 $46,515 942,428
(Indirect
Direct)
View
2021-06-07
Sale
2021-06-09
4:35 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,750 $26.35 $46,113 936,801
(Indirect
Direct)
View
2021-05-07
Sale
2021-05-11
11:47 am
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
750 $35 $26,250 937,545
(Indirect
Direct)
View
2021-05-05
Sale
2021-05-07
11:29 am
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,750 $34 $59,500 938,295
(Indirect
Direct)
View
2021-04-30
Sale
2021-05-04
3:00 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,500 $35 $52,500 804,553
(Indirect
Direct)
View
2021-04-05
Sale
2021-04-06
5:30 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,750 $29.93 $52,378 806,053
(Indirect
Direct)
View
2021-03-05
Sale
2021-03-05
3:56 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,750 $30.55 $53,463 907,003
(Indirect
Direct)
View
2021-03-02
Sale
2021-03-03
4:51 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
2,107 $35.19 $74,136 776,853
(Indirect
Direct)
View
2021-02-05
Sale
2021-02-08
4:00 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
10,000 $34.29 $342,916 914,452
(Indirect
Direct)
View
2021-01-05
Sale(A)
2021-01-07
3:13 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
10,000 $28.08 $280,754 924,452
(Indirect
Direct)
View
2020-09-29
Sale
2021-01-07
2:39 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
3,000 $30 $90,000 933,057
(Indirect
Direct)
View
2020-09-29
Sale
2020-10-01
9:02 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
3,000 $30 $90,000 933,057
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-08-05
Exercise
2021-08-09
6:51 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,000 $1.6806 941,428
(Direct)
View
2021-08-05
Exercise
2021-08-09
6:51 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,000 $0 941,428
(Direct)
View
2021-07-06
Exercise
2021-07-08
7:40 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,750 $1.6806 942,428
(Direct)
View
2021-07-06
Exercise
2021-07-08
7:40 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,750 $0 942,428
(Direct)
View
2021-06-18
Other
2021-06-22
6:35 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
7,377 $0 820,170
(Indirect)
View
2021-06-07
Exercise
2021-06-09
4:35 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,750 $1.6806 936,801
(Direct)
View
2021-06-07
Exercise
2021-06-09
4:35 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,750 $0 936,801
(Direct)
View
2021-05-07
Exercise
2021-05-11
11:47 am
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
750 $1.6806 937,545
(Direct)
View
2021-05-07
Exercise
2021-05-11
11:47 am
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
750 $0 937,545
(Direct)
View
2021-05-05
Exercise
2021-05-07
11:29 am
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,607 $1.6806 938,295
(Direct)
View
2021-05-05
Exercise
2021-05-07
11:29 am
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
1,607 $0 938,295
(Direct)
View
2021-03-03
Option Award
2021-03-05
3:56 pm
N/A
2031-03-03
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
131,900 $0 907,003
(Direct)
View
2021-02-05
Exercise
2021-02-08
4:00 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
10,000 $1.6806 914,452
(Direct)
View
2021-02-05
Exercise
2021-02-08
4:00 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
10,000 $0 914,452
(Direct)
View
2021-01-05
Exercise(A)
2021-01-07
3:13 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
10,000 $1.6806 924,452
(Direct)
View
2021-01-05
Exercise(A)
2021-01-07
3:13 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
10,000 $0 924,452
(Direct)
View
2020-09-29
Exercise
2021-01-07
2:39 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
3,000 $1.6806 933,057
(Direct)
View
2020-09-29
Exercise
2021-01-07
2:39 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
3,000 $0 933,057
(Direct)
View
2020-09-29
Exercise
2020-10-01
9:02 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
3,000 $1.6806 933,057
(Direct)
View
2020-09-29
Exercise
2020-10-01
9:02 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
President and CEO
3,000 $0 933,057
(Direct)
View
(A) Indicate amendment filing.
Goto Prev, 0, 1